Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00815711 · ClinicalTrials.gov registry record
Idiopathic Pulmonary Fibrosis Registry for Future Studies
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 13
- Enrollment target
NCT00815711: Completed study, sponsored by Ohio State University.
NCT00815711 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00815711 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.
Primary Outcome
To establish a framework in which biologic samples and physiologic measures from patients with IPF can be longitudinally collected and evaluated
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-12-01 |
| Est. Completion | 2015-06-10 |
What the finished NCT00815711 record still lists
NCT00815711 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00815711 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00815711 about?
NCT00815711 is a clinical study titled "Idiopathic Pulmonary Fibrosis Registry for Future Studies". To establish a registry of patients for future studies of Inflammation in Interstitial Lung Disease/Idiopathic Pulmonary Fibrosis.
What is the current status of trial NCT00815711?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2008-12-01. Estimated completion is 2015-06-10.
Who is sponsoring clinical trial NCT00815711?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI